S. Puckett

发表

Changes in Susceptibility to Oncolytic Vesicular Stomatitis Virus during Progression of Prostate Cancer

S. Cramer, D. Lyles, P. Antinozzi, 2015, Journal of Virology.

Protection against Lethal Vaccinia Virus Challenge by Using an Attenuated Matrix Protein Mutant Vesicular Stomatitis Virus Vaccine Vector Expressing Poxvirus Antigens

S. Mizel, D. Lyles, S. Puckett, 2010, Journal of Virology.

Vesicular Stomatitis Virus M Protein Mutant Stimulates Maturation of Toll-Like Receptor 7 (TLR7)-Positive Dendritic Cells through TLR-Dependent and -Independent Mechanisms (cid:1)

D. Lyles, E. Hiltbold, S. Puckett, 2009 .

Immunogenicity in African Green Monkeys of M Protein Mutant Vesicular Stomatitis Virus Vectors and Contribution of Vector-Encoded Flagellin

D. Lyles, M. Jorgensen, S. Puckett, 2018, Vaccines.

Inhibition of Host Transcription by Vesicular Stomatitis Virus Involves a Novel Mechanism That Is Independent of Phosphorylation of TATA-Binding Protein (TBP) or Association of TBP with TBP-Associated Factor Subunits

D. Lyles, Hang Yuan, S. Puckett, 2001, Journal of Virology.

Dynamic Actin Filament Traps Mediate Active Diffusion of Vesicular Stomatitis Virus Ribonucleoproteins

Steven Moran, J. Macosko, D. Lyles, 2022, Journal of virology.

Stimulation of Human Dendritic Cells by Wild-Type and M Protein Mutant Vesicular Stomatitis Viruses Engineered To Express Bacterial Flagellin

S. Mizel, D. Lyles, S. Puckett, 2010, Journal of Virology.

Early Steps of the Virus Replication Cycle Are Inhibited in Prostate Cancer Cells Resistant to Oncolytic Vesicular Stomatitis Virus

D. Lyles, S. Puckett, Maryam Ahmed, 2008, Journal of Virology.

Immune Response in the Absence of Neurovirulence in Mice Infected with M Protein Mutant Vesicular Stomatitis Virus

N. Kock, D. Lyles, S. Puckett, 2008, Journal of Virology.

Ability of the Matrix Protein of Vesicular Stomatitis Virus To Suppress Beta Interferon Gene Expression Is Genetically Correlated with the Inhibition of Host RNA and Protein Synthesis

D. Lyles, S. Puckett, L. Poliquin, 2003, Journal of Virology.

Diversity in responses to oncolytic Lassa-vesicular stomatitis virus in patient-derived glioblastoma cells

A. N. van den Pol, Teddy E. Kim, W. Debinski, 2021, Molecular therapy oncolytics.

MAP3K7 and CHD1 Are Novel Mediators of Resistance to Oncolytic Vesicular Stomatitis Virus in Prostate Cancer Cells

L. Miller, J. Chou, S. Cramer, 2020, Molecular therapy oncolytics.

Susceptibility of breast cancer cells to an oncolytic matrix (M) protein mutant of vesicular stomatitis virus

D. Lyles, S. Puckett, M. Ahmed, 2010, Cancer Gene Therapy.

Vesicular Stomatitis Virus M Protein Mutant Stimulates Maturation of Toll-Like Receptor 7 (TLR7)-Positive Dendritic Cells through TLR-Dependent and -Independent Mechanisms

D. Lyles, E. Hiltbold, S. Puckett, 2009, Journal of Virology.